184 related articles for article (PubMed ID: 17142863)
1. Evidence regarding a stem cell origin of hepatocellular carcinoma.
Shupe T; Petersen BE
Stem Cell Rev; 2005; 1(3):261-4. PubMed ID: 17142863
[TBL] [Abstract][Full Text] [Related]
2. Liver stem cells: implications for hepatocarcinogenesis.
Alison MR
Stem Cell Rev; 2005; 1(3):253-60. PubMed ID: 17142862
[TBL] [Abstract][Full Text] [Related]
3. Defeating EpCAM(+) liver cancer stem cells by targeting chromatin remodeling enzyme CHD4 in human hepatocellular carcinoma.
Nio K; Yamashita T; Okada H; Kondo M; Hayashi T; Hara Y; Nomura Y; Zeng SS; Yoshida M; Hayashi T; Sunagozaka H; Oishi N; Honda M; Kaneko S
J Hepatol; 2015 Nov; 63(5):1164-72. PubMed ID: 26095183
[TBL] [Abstract][Full Text] [Related]
4. Tg737 regulates epithelial-mesenchymal transition and cancer stem cell properties via a negative feedback circuit between Snail and HNF4α during liver stem cell malignant transformation.
Huang Q; Pu M; Zhao G; Dai B; Bian Z; Tang H; Chen C; Liu W; Qu X; Shen L; Tao K
Cancer Lett; 2017 Aug; 402():52-60. PubMed ID: 28536011
[TBL] [Abstract][Full Text] [Related]
5. Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma.
Sell S; Dunsford HA
Am J Pathol; 1989 Jun; 134(6):1347-63. PubMed ID: 2474256
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic protein-9 is a potent growth inhibitor of hepatocellular carcinoma and reduces the liver cancer stem cells population.
Jung JW; Yoon SM; Kim S; Jeon YH; Yoon BH; Yang SG; Kim MK; Choe S; Kuo MM
Oncotarget; 2016 Nov; 7(45):73754-73768. PubMed ID: 27650540
[TBL] [Abstract][Full Text] [Related]
7. Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway.
Cao L; Fan X; Jing W; Liang Y; Chen R; Liu Y; Zhu M; Jia R; Wang H; Zhang X; Zhang Y; Zhou X; Zhao J; Guo Y
Oncotarget; 2015 Mar; 6(9):6627-40. PubMed ID: 25749383
[TBL] [Abstract][Full Text] [Related]
8. Transient receptor potential vanilloid-type 2 targeting on stemness in liver cancer.
Hu Z; Cao X; Fang Y; Liu G; Xie C; Qian K; Lei X; Cao Z; Du H; Cheng X; Xu X
Biomed Pharmacother; 2018 Sep; 105():697-706. PubMed ID: 29906748
[TBL] [Abstract][Full Text] [Related]
9. A ΔRaf1-ER-inducible oncogenic zebrafish liver cell model identifies hepatocellular carcinoma signatures.
He S; Krens SG; Zhan H; Gong Z; Hogendoorn PC; Spaink HP; Snaar-Jagalska BE
J Pathol; 2011 Sep; 225(1):19-28. PubMed ID: 21744342
[TBL] [Abstract][Full Text] [Related]
10. The mitochondrial type IB topoisomerase drives mitochondrial translation and carcinogenesis.
Baechler SA; Factor VM; Dalla Rosa I; Ravji A; Becker D; Khiati S; Miller Jenkins LM; Lang M; Sourbier C; Michaels SA; Neckers LM; Zhang HL; Spinazzola A; Huang SN; Marquardt JU; Pommier Y
Nat Commun; 2019 Jan; 10(1):83. PubMed ID: 30622257
[TBL] [Abstract][Full Text] [Related]
11. Cancer stem cells in hepatocellular carcinomas.
Das P; Gupta SD
Indian J Med Res; 2015 Oct; 142(4):362-5. PubMed ID: 26609026
[No Abstract] [Full Text] [Related]
12. Isolation and characterization of hepatic cancer cells with stem-like properties from hepatocellular carcinoma.
Tomuleasa C; Soritau O; Rus-Ciuca D; Pop T; Todea D; Mosteanu O; Pintea B; Foris V; Susman S; Kacsó G; Irimie A
J Gastrointestin Liver Dis; 2010 Mar; 19(1):61-7. PubMed ID: 20361077
[TBL] [Abstract][Full Text] [Related]
13. Krüppel-like factor 8 promotes cancer stem cell-like traits in hepatocellular carcinoma through Wnt/β-catenin signaling.
Shen YN; He HG; Shi Y; Cao J; Yuan JY; Wang ZC; Shi CF; Zhu N; Wei YP; Liu F; Huang JL; Yang GS; Lu JH
Mol Carcinog; 2017 Feb; 56(2):751-760. PubMed ID: 27478926
[TBL] [Abstract][Full Text] [Related]
14. High expression of MAGE-A9 contributes to stemness and malignancy of human hepatocellular carcinoma.
Wei Y; Wang Y; Gong J; Rao L; Wu Z; Nie T; Shi D; Zhang L
Int J Oncol; 2018 Jan; 52(1):219-230. PubMed ID: 29138811
[TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance in hepatic cancer stem cells: the emerging role of miRNAs.
Sukowati CH; Anfuso B; Pascut D; Tiribelli C
Expert Rev Gastroenterol Hepatol; 2015 Jun; 9(6):723-5. PubMed ID: 25920931
[TBL] [Abstract][Full Text] [Related]
16. Liver cancer stem cells.
Sell S; Leffert HL
J Clin Oncol; 2008 Jun; 26(17):2800-5. PubMed ID: 18539957
[TBL] [Abstract][Full Text] [Related]
17. Proliferation inhibition and differentiation induction of hepatic cancer stem cells by knockdown of BC047440: a potential therapeutic target of stem cell treatment for hepatocellular carcinoma.
You N; Zheng L; Liu W; Zhong X; Wang W; Li J
Oncol Rep; 2014 Apr; 31(4):1911-20. PubMed ID: 24573111
[TBL] [Abstract][Full Text] [Related]
18. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
[TBL] [Abstract][Full Text] [Related]
19. Road to stemness in hepatocellular carcinoma.
Flores-Téllez TN; Villa-Treviño S; Piña-Vázquez C
World J Gastroenterol; 2017 Oct; 23(37):6750-6776. PubMed ID: 29085221
[TBL] [Abstract][Full Text] [Related]
20. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
